Press Releases

Press Release | July 20, 2022

Geneoscopy to Join Fight CRC at the White House to Address Colorectal Cancer Screening Needs

Press Release | June 21, 2022

Geneoscopy Announces Formation of Scientific Advisory Board to Inform Strategy for the Advancement of Gastrointestinal Health

Press Release | May 23, 2022

Geneoscopy Cost-Effectiveness Modeling Data Demonstrates Potential to Reduce Colorectal Cancer Cases and Deaths in the United States with RNA-FIT Screening Test

Press Release | January 20, 2022

Geneoscopy Tackles Healthcare Disparities in Pivotal Colorectal Cancer Clinical Trial Utilizing a Digital Recruitment Strategy

Press Release | November 16, 2021

Geneoscopy Closes $105M in Financing to Advance its Noninvasive Multifactor RNA Screening Test for Colorectal Cancer Prevention

Press Release | October 18, 2021

Geneoscopy Appoints Dr. Haytham Gareer as Chief Medical Officer

Press Release | October 13, 2021

Geneoscopy Honored by Goldman Sachs for Entrepreneurship

Press Release | July 12, 2021

Geneoscopy Enrolls First Patients in CRC-PREVENT U.S. Pivotal Trial

Press Release | May 25, 2021

Geneoscopy Announces Publication of Peer-Reviewed Article Highlighting Effective Noninvasive Screening Test for Colorectal Cancer Prevention

Press Release | March 17, 2021

Geneoscopy Appoints Don Hardison to its Strategic Advisory Board

Press Release | March 03, 2021

Geneoscopy Appoints Vince Wong as Chief Commercial Officer

Press Release | Novemember 19, 2020

Geneoscopy Announces Positive Results of Colorectal Cancer Screening Test in Prospective, Multicenter Clinical Study

Press Release | January 13, 2020

Geneoscopy’s Preventive Screening Test for Colorectal Cancer and Precancerous Adenomas Earns FDA Breakthrough Device Designation

Press Release | October 02, 2019

Geneoscopy Raises $6.9 Million to Advance Preventive Screening Test for Colorectal Cancer and Advanced Adenomas

Podcasts & Videos

Video | January 25, 2022

Podcast | January 25, 2022